Quick Answer
PURE BIOSCIENCE, INC. reported Cash and Equivalents of $334.0 thousand for fiscal year 2025.
PURE BIOSCIENCE, INC. Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $334.0K | -4.3% |
| 2024 | $349.0K | -68.1% |
| 2023 | $1.09M | -67.7% |
| 2022 | $3.39M | +41.9% |
| 2021 | $2.39M | -37.7% |
| 2020 | $3.84M | +864.6% |
| 2019 | $398.0K | -53.2% |
| 2018 | $851.0K | -48.1% |
| 2017 | $1.64M | -68.4% |
| 2016 | $5.19M | +293.2% |
| 2015 | $1.32M | +1436.0% |
| 2014 | $86.0K | +168.8% |
| 2013 | $32.0K | -96.4% |
| 2012 | $877.0K | -51.1% |
| 2011 | $1.79M | -18.2% |
| 2010 | $2.19M | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| January 31, 2026 | $198.0K | -2.0% | -54.4% |
| October 31, 2025 | $434.0K | +25.4% | +29.9% |
| July 31, 2025 | $334.0K | -4.3% | -38.1% |
| April 30, 2025 | $540.0K | +22.2% | +167.3% |
| January 31, 2025 | $202.0K | -63.7% | -41.6% |
| October 31, 2024 | $346.0K | -76.0% | -0.9% |
| July 31, 2024 | $349.0K | -68.1% | -21.0% |
| April 30, 2024 | $442.0K | -43.4% | -20.6% |
- PURE BIOSCIENCE, INC. showed a decrease of -4.3% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2010–2025 period, PURE BIOSCIENCE, INC.’s cash and equivalents has declined by 84.8% (from $2.19 million to $334.0 thousand).
- The most recent figure is from PURE BIOSCIENCE, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on October 29, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: